Literature DB >> 31763046

First case of Desulfovibrio desulfuricans bacteraemia successfully identified using MALDI-TOF MS.

R Nasreddine1, M A Argudin2, M Herpol2, V Y Miendje Deyi2, N Dauby1.   

Abstract

Desulfovibrio species are anaerobic Gram-negative bacilli that make up part of the human gastrointestinal and vaginal flora. Infection with these bacteria is usually secondary to an intra-abdominal source. Identification of these bacteria is possible using available contemporary methods. We report the first case of Desulfovibrio desulfuricans bacteraemia identified using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS).
© 2019 The Authors.

Entities:  

Keywords:  16S rRNA gene sequencing; Bacteraemia; Desulfovibrio desulfuricans; MALDI-TOF MS

Year:  2019        PMID: 31763046      PMCID: PMC6859274          DOI: 10.1016/j.nmni.2019.100614

Source DB:  PubMed          Journal:  New Microbes New Infect        ISSN: 2052-2975


Case presentation

A 53-year-old man presented to the emergency department at our institution with fever, abdominal pain, and obstipation. The patient had undergone, in his home country, surgical resection of a colorectal adenocarcinoma and underwent restoration of bowel continuity 2 months prior to presentation. The patient reported taking multiple doses of laxative in the preceding few days. Computed tomography scan of the abdomen revealed an intraluminal irregularity proximal to the anastomotic site resulting in complete bowel obstruction without signs of perforation. Two sets of aerobic and anaerobic peripheral blood cultures were performed (Bactec FX; Becton Dickinson, Franklin Lakes, NJ, USA) and piperacillin–tazobactam was started empirically. In the emergency department, the patient spontaneously evacuated a surgical compress followed by stool and intestinal gas. After 78 h of incubation, one anaerobic blood culture bottle signalled positive and was subcultured on Columbia and Schaedler agar. Gram staining showed curved gram-negative bacilli. Under anaerobic conditions, growth was observed after 48 h of incubation at 35°C. Employing matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and using the direct smear procedure without protein extraction (Biotyper IVD 4.2.80; Bruker Daltonics, Bremen, Germany), the colonies were identified as Desulfovibrio desulfuricans (best-match score: 2.25). The isolate was subjected to 16S rRNA gene sequencing using universal primers. A BLAST search in the GenBank database using the sequence obtained (Accession No. MN306006.1) showed a 99.46% concordance with Desulfovibrio desulfuricans reference strain Essex 6 (Accession No. NR_104990.1). Antibiotic susceptibilities were determined using MIC gradient tests (Etest® bioMérieux, Marcy-l’Etoile, France) on Brucella HK agar. According to the EUCAST 2019 guidelines (v 9.0), the isolate was sensitive to metronidazole (MIC 0.016 mg/L), amoxicillin–clavulanic acid (MIC 0.094 mg/L), imipenem (MIC 0.25 mg/L), and clindamycin (MIC 0.5 mg/L), while it was found to be resistant to piperacillin–tazobactam (MIC 64 mg/L). Antibiotic therapy was switched to amoxicillin–clavulanic acid and the patient was ultimately discharged with complete recovery. Desulfovibrio species are non-fermenting, anaerobic Gram-negative bacilli found in the environment, such as in soil and sewage [1]. These bacteria are also part of human gastrointestinal and vaginal flora [2,3]. Cases of bacteraemia due to D. desulfuricans have been reported previously [1,[4], [5], [6], [7]]. All patients were aged >60, the source of infection was always intra-abdominal (with the majority due to appendicitis or intra-abdominal abscess), and D. desulfuricans bacteraemia was most often monomicrobial. To the best of our knowledge, this is the first case of D. desulfuricans identified by MALDI-TOF MS. In the aforementioned reports, identification was always performed using either 16S rRNA gene sequencing alone or in combination with phenotypic testing, which is costly and time-consuming. This case serves as a reminder of the improved efficacy in microbiological diagnosis provided by MALDI-TOF MS [8]. Effective treatment options for Desulfovibrio desulfuricans infection include clindamycin, carbapenem, and metronidazole [2,9]. The antibiotic susceptibility profile of the isolate in this case (sensitive to amoxicillin–clavulanic acid and resistant to piperacillin–tazobactam) has been reported previously [1,2,[4], [5], [6], [7],9]. Indeed, certain D. desulfuricans strains can produce an Ambler class A extended-spectrum β-lactamase [10]. However, it seems that this bacterium may have other mechanisms of β-lactam resistance which have yet to be determined [10].

Conflict of interest

None to declare.
  10 in total

1.  Antimicrobial susceptibilities of clinical Desulfovibrio isolates.

Authors:  A Lozniewski; R Labia; X Haristoy; F Mory
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

2.  Desulfovibrio desulfuricans bacteremia in an immunocompromised host with a liver graft and ulcerative colitis.

Authors:  Isabel Verstreken; Wim Laleman; Georges Wauters; Jan Verhaegen
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

Review 3.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology.

Authors:  Andrew E Clark; Erin J Kaleta; Amit Arora; Donna M Wolk
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 4.  Desulfovibrio desulfuricans bacteremia: A case report and literature review.

Authors:  Hideharu Hagiya; Keigo Kimura; Isao Nishi; Norihisa Yamamoto; Hisao Yoshida; Yukihiro Akeda; Kazunori Tomono
Journal:  Anaerobe       Date:  2018-01-04       Impact factor: 3.331

5.  Desulfovibrio desulfuricans bacteremia in a patient hospitalized with acute cerebral infarction: case report and review.

Authors:  Shigehiro Hagiwara; Atsushi Yoshida; Yuki Omata; Yumiko Tsukada; Hirohumi Takahashi; Hitoshi Kamewada; Saiko Koike; Katsuko Okuzumi; Akira Hishinuma; Kunihiko Kobayashi; Masayasu Nakano
Journal:  J Infect Chemother       Date:  2013-12-11       Impact factor: 2.211

6.  First isolation of Desulfovibrio from the human vaginal flora.

Authors:  Suguru Ichiishi; Kaori Tanaka; Kenichi Nakao; Koji Izumi; Hiroshige Mikamo; Kunitomo Watanabe
Journal:  Anaerobe       Date:  2010-02-14       Impact factor: 3.331

7.  Biochemical-genetic analysis and distribution of DES-1, an Ambler class A extended-spectrum beta-lactamase from Desulfovibrio desulfuricans.

Authors:  Anne-Sophie Morin; Laurent Poirel; Francine Mory; Roger Labia; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

8.  Susceptibilities of 23 Desulfovibrio isolates from humans.

Authors:  Ken-ichi Nakao; Kaori Tanaka; Suguru Ichiishi; Hiroshige Mikamo; Toshiyuki Shibata; Kunitomo Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

Review 9.  Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections.

Authors:  Ellie J C Goldstein; Diane M Citron; Victoria A Peraino; Sally A Cross
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  A Case of Liver Abscess with Desulfovibrio desulfuricans Bacteremia.

Authors:  Saho Koyano; Keita Tatsuno; Mitsuhiro Okazaki; Kiyofumi Ohkusu; Takashi Sasaki; Ryoichi Saito; Shu Okugawa; Kyoji Moriya
Journal:  Case Rep Infect Dis       Date:  2015-01-08
  10 in total
  1 in total

Review 1.  First case of a renal cyst infection caused by Desulfovibrio: a case report and literature review.

Authors:  Yoshiki Okamoto; Yoei Miyabe; Momoko Seki; Yusuke Ushio; Keisuke Sato; Eri Kasama; Kenichi Akiyama; Kazunori Karasawa; Keiko Uchida; Ken Kikuchi; Kosaku Nitta; Takahito Moriyama; Junichi Hoshino
Journal:  BMC Nephrol       Date:  2022-05-23       Impact factor: 2.585

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.